What is he best known for?
The fields of study he is best known for:
Mingdong Huang mainly focuses on Biochemistry, Cell biology, Lanthanide, Nanotechnology and Plasma protein binding.
He focuses mostly in the field of Biochemistry, narrowing it down to topics relating to Urokinase and, in certain cases, Vitronectin.
His Vitronectin research is multidisciplinary, incorporating elements of Plasminogen activator and Fibrinolysis.
His Cell biology research incorporates themes from Immunology, Receptor, Major histocompatibility complex and T-cell receptor.
His Nanotechnology study incorporates themes from Doping, Singlet oxygen, Ligand, Photodynamic therapy and Avidin.
His research in Plasma protein binding intersects with topics in Protein structure, Monosaccharide, Human serum albumin and Binding site.
His most cited work include:
- Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen (632 citations)
- Amine-Functionalized Lanthanide-Doped KGdF4 Nanocrystals as Potential Optical/Magnetic Multimodal Bioprobes (327 citations)
- Lanthanide-doped LiLuF(4) upconversion nanoprobes for the detection of disease biomarkers. (300 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Biochemistry, Plasminogen activator, Urokinase receptor, Stereochemistry and Photodynamic therapy.
His study in Proteases, Serine protease, Binding site, Protein structure and Peptide is carried out as part of his studies in Biochemistry.
His research on Plasminogen activator also deals with topics like
- Urokinase that connect with fields like Pharmacology,
- Fibrinolysis which is related to area like Plasminogen activator inhibitor-1.
His Urokinase receptor research is multidisciplinary, incorporating perspectives in Biophysics, Vitronectin and Cell biology.
The study incorporates disciplines such as Antibody and Crystal structure in addition to Stereochemistry.
His biological study spans a wide range of topics, including Cancer, Cancer research, In vivo and Photosensitizer.
He most often published in these fields:
- Biochemistry (49.10%)
- Plasminogen activator (35.13%)
- Urokinase receptor (25.45%)
What were the highlights of his more recent work (between 2018-2021)?
- Plasminogen activator (35.13%)
- Cancer research (15.05%)
- Cancer (11.47%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Plasminogen activator, Cancer research, Cancer, In vivo and Photodynamic therapy.
His study in Plasminogen activator focuses on Urokinase receptor in particular.
His Urokinase receptor research includes themes of Ligand, Snake venom, Stereochemistry, Cell surface receptor and Binding site.
His Cancer research study combines topics in areas such as Matriptase, Metastasis and Drug delivery.
The Photodynamic therapy study combines topics in areas such as Antitumor therapy, Phthalocyanine, Reactive oxygen species, Photosensitizer and Combination therapy.
His research on Serine protease concerns the broader Biochemistry.
Between 2018 and 2021, his most popular works were:
- Therapeutics targeting the fibrinolytic system. (14 citations)
- Composite of silver nanoparticles and photosensitizer leads to mutual enhancement of antimicrobial efficacy and promotes wound healing (12 citations)
- Nanoparticle Binding to Urokinase Receptor on Cancer Cell Surface Triggers Nanoparticle Disintegration and Cargo Release. (12 citations)
In his most recent research, the most cited papers focused on:
Mingdong Huang spends much of his time researching Plasminogen activator, Cancer research, Cancer, Serine protease and Photodynamic therapy.
His work carried out in the field of Plasminogen activator brings together such families of science as Fibrinolysis, Antigen, Chromatography and Urokinase.
His Urokinase research integrates issues from Proteases, Serine and Diuretic.
His Cancer research research is multidisciplinary, relying on both Human serum albumin, Urokinase receptor, Metastasis, Activator and Cytotoxicity.
His study focuses on the intersection of Serine protease and fields such as Pharmacology with connections in the field of Drug resistance and In vivo.
He combines subjects such as Drug carrier, Drug delivery, Combination therapy and Photosensitizer with his study of Photodynamic therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
